| Dr Scott Schwartz, MD | |
|
130 Town Center Dr Ste 203, Troy, MI 48084-1744 | |
| (947) 999-8244 | |
| (947) 999-8244 |
| Full Name | Dr Scott Schwartz |
|---|---|
| Gender | Male |
| Speciality | Interventional Radiology |
| Experience | 19 Years |
| Location | 130 Town Center Dr Ste 203, Troy, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821209065 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 4301085726 (Michigan) | Secondary |
| 2085R0204X | Radiology - Vascular & Interventional Radiology | 4301085726 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Henry Ford West Bloomfield Hospital | West bloomfield, MI | Hospital |
| Henry Ford Hospital | Detroit, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Henry Ford Medical Group | 0547178311 | 2095 |
| Michigan Institute Of Urology Pc | 1052223492 | 76 |
News Archive
Tolero Pharmaceuticals, Inc., a clinical-stage company developing treatments for serious hematological diseases, today announced that the U.S. Food and Drug Administration has granted Orphan Drug designation for Alvocidib for the treatment of patients with acute myeloid leukemia (AML).
KARL STORZ and VirtaMed, leader in medical training simulation, introduce a novel mixed reality simulator bringing innovation to laparoscopic skills training.
For many newborn babies, an enzyme that breaks down the molecule bilirubin doesn't activate right away. The resulting bilirubin buildup can lead to jaundice, a typically harmless condition that causes a baby's skin to temporarily appear yellow.
It doesn't matter if it's rye, oats, or wheat. As long as it is wholegrain, it can prevent type 2 diabetes. This is the finding of a new study from researchers at Chalmers University of Technology, Sweden, and the Danish Cancer Society Research Center.
› Verified 1 days ago
| Entity Name | Henry Ford Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134144801 PECOS PAC ID: 0547178311 Enrollment ID: O20031105000139 |
News Archive
Tolero Pharmaceuticals, Inc., a clinical-stage company developing treatments for serious hematological diseases, today announced that the U.S. Food and Drug Administration has granted Orphan Drug designation for Alvocidib for the treatment of patients with acute myeloid leukemia (AML).
KARL STORZ and VirtaMed, leader in medical training simulation, introduce a novel mixed reality simulator bringing innovation to laparoscopic skills training.
For many newborn babies, an enzyme that breaks down the molecule bilirubin doesn't activate right away. The resulting bilirubin buildup can lead to jaundice, a typically harmless condition that causes a baby's skin to temporarily appear yellow.
It doesn't matter if it's rye, oats, or wheat. As long as it is wholegrain, it can prevent type 2 diabetes. This is the finding of a new study from researchers at Chalmers University of Technology, Sweden, and the Danish Cancer Society Research Center.
› Verified 1 days ago
| Entity Name | Michigan Institute Of Urology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427027416 PECOS PAC ID: 1052223492 Enrollment ID: O20031125000770 |
News Archive
Tolero Pharmaceuticals, Inc., a clinical-stage company developing treatments for serious hematological diseases, today announced that the U.S. Food and Drug Administration has granted Orphan Drug designation for Alvocidib for the treatment of patients with acute myeloid leukemia (AML).
KARL STORZ and VirtaMed, leader in medical training simulation, introduce a novel mixed reality simulator bringing innovation to laparoscopic skills training.
For many newborn babies, an enzyme that breaks down the molecule bilirubin doesn't activate right away. The resulting bilirubin buildup can lead to jaundice, a typically harmless condition that causes a baby's skin to temporarily appear yellow.
It doesn't matter if it's rye, oats, or wheat. As long as it is wholegrain, it can prevent type 2 diabetes. This is the finding of a new study from researchers at Chalmers University of Technology, Sweden, and the Danish Cancer Society Research Center.
› Verified 1 days ago
| Entity Name | Henry Ford Macomb Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134265986 PECOS PAC ID: 7911808381 Enrollment ID: O20040119000142 |
News Archive
Tolero Pharmaceuticals, Inc., a clinical-stage company developing treatments for serious hematological diseases, today announced that the U.S. Food and Drug Administration has granted Orphan Drug designation for Alvocidib for the treatment of patients with acute myeloid leukemia (AML).
KARL STORZ and VirtaMed, leader in medical training simulation, introduce a novel mixed reality simulator bringing innovation to laparoscopic skills training.
For many newborn babies, an enzyme that breaks down the molecule bilirubin doesn't activate right away. The resulting bilirubin buildup can lead to jaundice, a typically harmless condition that causes a baby's skin to temporarily appear yellow.
It doesn't matter if it's rye, oats, or wheat. As long as it is wholegrain, it can prevent type 2 diabetes. This is the finding of a new study from researchers at Chalmers University of Technology, Sweden, and the Danish Cancer Society Research Center.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Scott Schwartz, MD 20952 E 12 Mile Rd Ste 200, Saint Clair Shores, MI 48081-3203 Ph: (586) 771-4820 | Dr Scott Schwartz, MD 130 Town Center Dr Ste 203, Troy, MI 48084-1744 Ph: (947) 999-8244 |
News Archive
Tolero Pharmaceuticals, Inc., a clinical-stage company developing treatments for serious hematological diseases, today announced that the U.S. Food and Drug Administration has granted Orphan Drug designation for Alvocidib for the treatment of patients with acute myeloid leukemia (AML).
KARL STORZ and VirtaMed, leader in medical training simulation, introduce a novel mixed reality simulator bringing innovation to laparoscopic skills training.
For many newborn babies, an enzyme that breaks down the molecule bilirubin doesn't activate right away. The resulting bilirubin buildup can lead to jaundice, a typically harmless condition that causes a baby's skin to temporarily appear yellow.
It doesn't matter if it's rye, oats, or wheat. As long as it is wholegrain, it can prevent type 2 diabetes. This is the finding of a new study from researchers at Chalmers University of Technology, Sweden, and the Danish Cancer Society Research Center.
› Verified 1 days ago
Ming Lin Hsieh, Radiology Medicare: Accepting Medicare Assignments Practice Location: 44201 Dequindre Rd, Troy, MI 48085 Phone: 248-964-5190 | |
Marie Konczalski, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 44201 Dequindre Rd, Beaumont Hospital - Troy, Troy, MI 48085 Phone: 248-964-5190 Fax: 248-964-5199 | |
Brian Berger, Radiology Medicare: Accepting Medicare Assignments Practice Location: 44201 Dequindre Rd, Troy, MI 48085 Phone: 248-964-5190 | |
Tarun Gupta, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 44201 Dequindre Rd, Troy, MI 48085 Phone: 248-964-5000 | |
Robert Warren Mendelson, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 2541 Manchester Ct, Troy, MI 48098 Phone: 248-879-8100 Fax: 248-879-8300 | |
Dr. Krisha J Howell, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4550 Investment Dr Ste B111, Troy, MI 48098 Phone: 248-952-5019 | |
Stephen Zintsmaster, Radiology Medicare: Accepting Medicare Assignments Practice Location: 44201 Dequindre Rd, Troy, MI 48085 Phone: 248-964-5190 Fax: 248-964-5199 |